N-Glycans in cancer progression

Glycobiology

Volumn 18, Issue 10, 2008, Pages 750-760

  Lau, Ken S ^a,b   Dennis, James W ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer; Cytokine signaling; Metabolism; N glycans

Indexed keywords

BETA1 6 N ACETYLGLUCOSAMINYLTRANSFERASE V; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR; GALECTIN 3; GLYCAN DERIVATIVE; HEXOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITIDE 3 PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL GROWTH; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; CELL SURFACE; ENDOCYTOSIS; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE LOSS; GENE MUTATION; GENE OVEREXPRESSION; GLYCOPROTEIN SYNTHESIS; GLYCOSYLATION; GOLGI COMPLEX; GROWTH INHIBITION; GROWTH REGULATION; INTRACELLULAR TRANSPORT; LIGAND BINDING; METASTASIS; MICROFILAMENT; N GLYCOSYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; DISEASE PROGRESSION; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASMS; POLYSACCHARIDES; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 53049084874     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwn071     Document Type: Review

References (106)

1. Ahmad N, Gabius HJ, Andre S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F, Brewer CF. 2003. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem. 279:10841-10847.
2. Apweiler R, Hermjakob H, Sharon N. 1999. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1473:4-8.
3. Banerjee S, Vishwanath P, Cui J, Kelleher DJ, Gilmore R, Robbins PW, Samuelson J. 2007. The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation. Proc Natl Acad Sci USA. 104:11676-11681.
4. Baselga J. 2006. Targeting tyrosine kinases in cancer: The second wave. Science. 312:1175-1178.
5. Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, Harding H, Novoa I, Varia M, Raleigh J, et al. 2005. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 24:3470-3481.
6. Boehmelt G, Fialka I, Brothers G. McGinley MD. Patterson SD, Mo R, Hui CC, Chung S, Huber LA, Mak TW, et al. 2000. Cloning and characterization of the murine glucosamine-6-phosphate acetyransferase EMeg32. J Biol Chem. 275:12821-12832.
7. Brewer CF, Miceli MC, Baum LG. 2002. Clusters, bundles, arrays and lattices: Novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol. 12:616-623.
8. Broschat KO, Gorka C. Page JD, Martin-Berger CL, Davies MS, Huang Hc HC, Gulve EA, Salsgiver WJ. Kasten TP. 2002. Kinetic characterization of human glutamme-fructose-6-phosphate amidotransferase: I. Potent feedback inhibition by glucosamine 6-phosphate. J Biol Chem. 277:14764-14770.
9. Brunet A, Sweeney LB, Sturgill JF, Chua. KF, Greer PI, Lin Y. Tran H, Ross SE, Mostoslavsky R. Cohen HY, et al. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 303:2011-2015.
10. Buckhaults P, Chen L, Fregien N, Pierce M. 1997. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J Biol Chem. 272:19575-19581.
11. Cantley LC. 2002. The phosphoinositide 3-kinase pathway. Science. 296:1655-1657.
12. Casal J, Lawrence PA, Struld G. 2006. Two separate molecular systems, Dachsous/Fat and Starry night/Frizzled, act independently to confer planar cell polarity. Development. 133:4561-4572.
13. Chaney W. Sundaram S, Friedman N, Stanley R 1989. The lec4A CHO glycosylation mutant arises from miscompartmentalization of a Golgi glycosyl-transferase. J Cell Biol. 109:2089-2096.
14. Cheung P. Dennis JW. 2007. Mgat5 and Pten interact to regulate cell growth and polarity. Glycobiology. 17:767-773.
15. Cheung P, Pawling J. Partridge EA, Sukhu B, Grynpas M, Dennis JW. 2007. Metabolic homeostasis and tissue renewal are dependent on beta1, 6GlcNAc-branched N-glycans. Glycobiology. 17:828-837.
16. Collins BE, Smith BA, Bengtson P, Paulson JC. 2006. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat Immunol 7:199-206.
17. Cooper DN. 2002. Galectinomics: Finding themes in complexity. Biochim Biophys Acta. 1572:209-231.
18. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S. 2003. Links between tumor suppressors: P53 is required for TGF-beta gene responses by cooperating with Smads. Cell. 113:301-314.
19. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol. 7:255-266.
20. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ. 1996. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 86:531-542.
21. Dam TK, Gabius HJ, Andre S, Kaltner H, Lensch M, Brewer CF. 2005. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry. 44:12564-12571.
22. Delacour D, Greb C, Koch A, Salomonsson E, Leffler H, Le Bivic A, Jacob R. 2007. Apical sorting by galectin-3-dependent glycoprotein clustering. Traffic. 8:379-388.
23. Demetriou M, Granovsky M, Quaggin S, Dennis JW. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N glycosylation. Nature. 409:733-739.
24. den Hertog J, Groen A, van der Wijk T. 2005. Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys. 434:11-15.
25. DeWitt A, Iida T, Lam HY, Hill V, Wiley HS, Lauffenburger DA. 2002. Affinity regulates spatial range of EGF receptor autocrine ligand binding. Dev Biol. 250:305-316.
26. Do K-Y, Fregien N, Pierce M, Cummings RD. 1994. Modification of glycoproteins by N-acetylglucosaminyltransferase V is greatly influenced by accessibility of the enzyme to oligosacharide acceptors. J Biol Chem. 269:23456-23464.
27. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC. 2005. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science. 308:1181-1184.
28. Fernandes B, Sagman U, Auger M, Demetriou M, Dennis JW. 1991. Beta1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 51:718-723.
29. Fernandes H, Cohen S, Bishayee S. 2001. Glycosylation-induced conformational modification positively regulates receptor-receptor association: A study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells. J Biol Chem. 276:5375-5383.
30. Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity. 16:769-777.
31. Fruman DA, Meyers RE, Cantley LC. 1998. Phosphoinositide kinases. Ann Rev Biochem. 67:481-507.
32. Funamoto S, Meili R, Lee S, Parry L, Firtel RA. 2002. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell. 109:611-623.
33. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nature Med. 6:306-312.
34. Grigorian A, Lee S-U, Tian W, Chen I-J, Gao G, Mendelsohn R, Dennis JW, Demetriou M. 2007. Control of T cell mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J Biol Chem. 282:20027-20035.
35. Gutternigg M, Kretschmer-Lubich D, Paschinger K, Rendic D, Hader J, Geier P, Ranftl R, Jantsch V, Lochnit G,Wilson IB. 2007. Biosynthesis of truncated N-linked oligosaccharides results from non-orthologous hexosaminidasemediated mechanisms in nematodes, plants, and insects. J Biol Chem. 282:27825-27840.
36. Guy CT, Cardiff RD, Muller WJ. 1998. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol. 12:954-961.
37. Harris H. 2004. Tumour suppression: Putting on the brakes. Nature. 427:201.
38. He J, Baum LG. 2006. Galectin interactions with extracellular matrix and effects on cellular function. Methods Enzymol. 417:247-256.
39. Helenius A, Aebi M. 2004. Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem. 73:1019-1049.
40. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, et al. 2002. Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim Biophys Acta. 1572:232-254.
41. Hirabayashi J, Kasai K. 1991. Effect of amino acid substitution by site-directed mutagenesis on the carbohydrate recognition and stability of human 14-kDa beta-galactoside-binding lectin. J Biol Chem. 266:23648-23653.
42. Hong M, Luo S, Baumeister P, Huang JM, Gogia RK, Li M, Lee AS. 2004. Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response. J Biol Chem. 279: 11354-11363.
43. Hughes RC. 1999. Secretion of the galectin family of mammalian carbohydratebinding proteins. Biochim Biophys Acta. 1473:172-185.
44. Inoki K, Corradetti MN, Guan KL. 2005. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 37:19-24.
45. Ioffe E, Stanley P. 1994. Mice lacking N acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc Natl Acad Sci USA. 91:728-732.
46. Ishida H, Togayachi A, Sakai T, Iwai T, Hiruma T, Sato T, Okubo R, Inaba N, Kudo T, Gotoh M, et al. 2005. A novel beta1,3-N acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly- N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett. 579:71-78.
47. Kang R, Saito H, Ihara Y, Miyoshi E, Koyama N, Sheng Y, Taniguchi N. 1996. Transcriptional regulation of the N acetylglucosaminyltranserase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem. 271:26706-26712.
48. Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffin JD, Sattler M. 2005. Activation of the P13K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood. 105:1717-1723.
49. Kinlough CL, Poland PA, Bruns JB, Harkleroad KL, Hughey RP. 2004. MUC1 membrane trafficking is modulated by multiple interactions. J Biol Chem. 279:53071-53077.
50. Kockeritz L, Doble B, Patel S, Woodgett JR. 2006. Glycogen synthase kinase-3 - an overview of an over-achieving protein kinase. Curr Drug Targets. 7:1377-1388.
51. Konishi A, Berk BC. 2003. Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells. J Biol Chem. 278:35049-35056.
52. Koshland DE Jr, Goldbeter A, Stock JB. 1982. Amplification and adaptation in regulatory and sensory systems. Science. 217:220-225.
53. Kuriyan J, Eisenberg D. 2007. The origin of protein interactions and allostery in colocalization. Nature. 450:983-990.
54. Lagana A, Goetz JG, Cheung P, Raz A, Dennis JW, Nabi IR. 2006. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol. 26:3181-3193.
55. Lajoie P, Partridge EA, Guay G, Goetz JG, Pawling J, Lagana A, Dennis JW, Nabi IR. 2007. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol. 179:341-356.
56. Lau K, Partridge EA, Silvescu CI, Grigorian A, Pawling J, Reinhold VN, Demetriou M, Dennis JW. 2007. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 129:123-124.
57. Lau KS, Khan S, Dennis JW. 2008. Genome-scale identification of UDP-GlcNAc-dependent pathways. Proteomics. 8:3294-3302.
58. -) null mice show mammary epithelial cell hyperplasia. Am J Pathol. 161:1357-1369.
59. Lee RT, Lee YC. 2000. Affinity enhancement by multivalent lectin-carbohydrate interaction. Glycoconj J. 17:543-551.
60. 2. J Biol Chem. 277:20336-20342.
61. Leevers SJ, McNeill H. 2005. Controlling the size of organs and organisms. Curr Opin Cell Biol. 17:604-609.
62. Leonard R, Rendic D, Rabouille C, Wilson IB, Preat T, Altmann F. 2006. The Drosophila fused lobes gene encodes an N acetylglucosaminidase involved in N-glycan processing. J Biol Chem. 281:4867-4875.
63. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA. 2004. Gene regulation and DNA damage in the ageing human brain. Nature. 429:883-891.
64. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. 2004. Cyclindependent kinases regulate the antiproliferative function of Smads. Nature. 430:226-231.
65. Mendelsohn R, Cheung P, Berger L, Partridge EA, Lau K, Pawling J, Dennis JW. 2007. Control of tumor metabolism and growth by N-glycan processing. Cancer Res. 67:9771-9780.
66. Metzler M, Gertz A, Sarkar M, Schachter H, Schrader JW, Marth JD. 1994. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13:2056-2065.
67. Nimnual AS, Taylor LJ, Bar-Sagi D. 2003. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol. 5:236-241.
68. Offterdinger M, Georget V, Girod A, Bastiaens PI. 2004. Imaging phosphorylation dynamics of the epidermal growth factor receptor. J Biol Chem. 279:36972-36981.
69. Oft M, Akhurst RJ, Balmain A. 2002. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nature Cell Biol. 4:487-494.
70. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 273:5419-5422.
71. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. 2005. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science. 307:1603-1609.
72. Pace KE, Lee C, Stewart PL, Baum LG. 1999. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol. 163:3801-3811.
73. Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF. 1997. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature. 385:537-540.
74. 2. Mol Cell Biol 24:4384-4394.
75. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW. 2004. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 306:120-124.
76. Patnaik SK, Potvin B, Carlsson S, et al. 2006. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells. Glycob. 16:305-317.
77. Pelkmans L, Fava E, Grabner H, Hannus M, Habermann B, Krausz E, Zerial M. 2005. Genome-wide analysis of human kinases in clathrin- and caveolae/ raft-mediated endocytosis. Nature. 436:78-86.
78. Petritsch C, Beug H, Balmain A, Oft M. 2000. TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 14:3093-3101.
79. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL. 2006. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 444: 761-765.
80. Reynolds AR, Tischer C, Verveer PJ, Rocks O, Bastiaens PI. 2003. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat Cell Biol. 5:447-453.
81. Roberts EC, Shapiro PS, Nahreini TS, Pages G, Pouyssegur J, Ahn NG. 2002. Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol Cell Biol. 22:7226-7241.
82. Sarkar M, Leventis PA, Silvescu CI, Reinhold VN, Schachter H, Boulianne GL. 2006. Null mutations in Drosophila N acetylglucosaminyltransferase I produce defects in locomotion and a reduced life span. J Biol Chem. 281:12776-12785.
83. Schachter H. 1986. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol. 64:163-181.
84. Scheel J, Srinivasan J, Honnert U, Henske A, Kurzchalia TV. 1999. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat Cell Biol. 1:127-129.
85. Schroder M, Kaufman RJ. 2005. The mammalian unfolded protein response. Annu Rev Biochem. 74:739-789.
86. Seelentag WK, Li WP, Schmitz SF, Metzger U, Aeberhard P, Heitz PU, Roth J. 1998. Prognostic value of beta1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res. 58:5559-5564.
87. Seoane J, Le HV, Shen L, Anderson SA, Massague J. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 117:211-223.
88. Shang J, Gao N, Kaufman RJ, Ron D, Harding HP, Lehrman MA. 2007. Translation attenuation by PERK balances ER glycoprotein synthesis with lipidlinked oligosaccharide flux. J Cell Biol. 176:605-616.
89. Shrivastava S, Chattopadhyay A. 2007. Influence of cholesterol and ergosterol on membrane dynamics using different fluorescent reporter probes. Biochem Biophys Res Commun. 356:705-710.
90. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ulrich A, McGuire WL. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science. 235:177-182.
91. Stroop CJ, Weber W, Gerwig GJ, Nimtz M, Kamerling JP, Vliegenthart JFG. 2000. Characterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptor. Glycobiology. 10:901-917.
92. Takamatsu S, Oguri S, Minowa MT, Yoshida A, Nakamura K, Takeuchi M, Kobata A. 1999. Unusually high expression of N acetylglucosaminyltransferase-IV a in human choriocarcinoma cell lines: A possible enzymatic basis of the formation of abnormal biantennary sugar chain. Cancer Res. 59:3949-3953.
93. Takenaka Y, Fukumori T, Raz A. 2004. Galectin-3 and metastasis. Glycoconj J. 19:543-549.
94. Thiery JP. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 15:740-746.
95. Togayachi A, Sato T, Narimatsu H. 2006. Comprehensive enzymatic characterization of glycosyltransferases with a beta3GT or beta4GT motif. Methods Enzymol. 416:91-102.
96. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG, et al. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol. 8:825-834.
97. Tsuda T, Ikeda Y, Taniguchi N. 2000. The Asn-420-linked sugar chain human epidermal growth factor receptor suppresses ligand-independent spontaneous oligomerization. Possible role of a specific sugar chain controllable receptor activation. J Biol Chem. 275:21988-21994.
98. Umana P, Bailey JE. 1997. A mathematical model of N-linked glycoform biosynthesis. Biotechnol Bioeng. 55:890-908.
99. Vazquez F, Matsuoka S, Sellers WR, Yanagida T, Ueda M, Devreotes PN. 2006. Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc Natl Acad Sci USA. 103:3633-3638.
100. Waldman BC, Rudnick G. 1990. UDP-GlcNAc transport across the Golgi membrane: Electroneutral exchange for dianionic UMP. Biochemistry. 29:44-52.
101. Weiner OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, Bourne HR. 2002. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol. 7:509-513.
102. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. 2005. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2:185-190.
103. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. 2007. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 445:656-660.
104. Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N. 1995. Suppression of lung metastasis of B16 mouse melanoma by N acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA. 92:8753-8758.
105. Zhang J, Zhang W, Zou D, Chen G, Wan T, Li N, Cao X. 2003. Cloning and functional characterization of GNPI2, a novel human homolog of glucosamine-6-phosphate isomerase/oscillin. J Cell Biochem. 88:932-940.
106. Zhu S, Hanneman A, Reinhold VN, Spence AM, Schachter H. 2004. Caenorhabditis elegans triple null mutant lacking UDP-N acetyl-D-glucosamine:aLpha-3-D-mannoside beta1,2-N acetylglucosaminyltransferase I. Biochem J. 382:995-1001.